Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven Chen, MD, MBA
Avelas Biosciences, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsd
San Diego, California, United States
- Medstar Washington Hospital
Washington D.C., District of Columbia, United States
- Mayo Clinic Jacksonville -- Center for Breast Health
Jacksonville, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Advocate Good Shepherd Hospital
Barrington, Illinois, United States
- William Beaumont Hospital
Royal Oak, Michigan, United States
- Unlv School of Medicine
Las Vegas, Nevada, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Montefiore Einstein Center for Cancer Care
The Bronx, New York, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Ohio State University, James Cancer Center
Columbus, Ohio, United States
- Roper St. Francis Hospital
Charleston, South Carolina, United States
- Swedish Cancer Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jul 2017
- Primary completion
- 8 Apr 2020
- Completion
- 18 Nov 2020
- Last update posted
- 11 Jun 2021
- Registered enrollment
- 92
- Registry id
- NCT03113825
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.